S&P 500   2,606.15 (+2.54%)
DOW   22,128.89 (+2.27%)
QQQ   190.96 (+3.05%)
AAPL   252.50 (+1.92%)
FB   163.45 (+4.25%)
MSFT   158.88 (+6.13%)
GOOGL   1,135.01 (+2.23%)
AMZN   1,964.98 (+3.41%)
CGC   14.45 (-0.96%)
NVDA   263.09 (+4.10%)
BABA   190.15 (+0.83%)
MU   45.32 (+4.23%)
GE   7.86 (+3.15%)
TSLA   510.21 (-0.81%)
AMD   48.21 (+3.50%)
T   29.86 (-0.07%)
ACB   0.94 (-9.66%)
F   5.01 (-3.47%)
NFLX   373.21 (+4.51%)
BAC   22.22 (+2.87%)
GILD   75.53 (+3.68%)
DIS   97.21 (+0.84%)
S&P 500   2,606.15 (+2.54%)
DOW   22,128.89 (+2.27%)
QQQ   190.96 (+3.05%)
AAPL   252.50 (+1.92%)
FB   163.45 (+4.25%)
MSFT   158.88 (+6.13%)
GOOGL   1,135.01 (+2.23%)
AMZN   1,964.98 (+3.41%)
CGC   14.45 (-0.96%)
NVDA   263.09 (+4.10%)
BABA   190.15 (+0.83%)
MU   45.32 (+4.23%)
GE   7.86 (+3.15%)
TSLA   510.21 (-0.81%)
AMD   48.21 (+3.50%)
T   29.86 (-0.07%)
ACB   0.94 (-9.66%)
F   5.01 (-3.47%)
NFLX   373.21 (+4.51%)
BAC   22.22 (+2.87%)
GILD   75.53 (+3.68%)
DIS   97.21 (+0.84%)
S&P 500   2,606.15 (+2.54%)
DOW   22,128.89 (+2.27%)
QQQ   190.96 (+3.05%)
AAPL   252.50 (+1.92%)
FB   163.45 (+4.25%)
MSFT   158.88 (+6.13%)
GOOGL   1,135.01 (+2.23%)
AMZN   1,964.98 (+3.41%)
CGC   14.45 (-0.96%)
NVDA   263.09 (+4.10%)
BABA   190.15 (+0.83%)
MU   45.32 (+4.23%)
GE   7.86 (+3.15%)
TSLA   510.21 (-0.81%)
AMD   48.21 (+3.50%)
T   29.86 (-0.07%)
ACB   0.94 (-9.66%)
F   5.01 (-3.47%)
NFLX   373.21 (+4.51%)
BAC   22.22 (+2.87%)
GILD   75.53 (+3.68%)
DIS   97.21 (+0.84%)
S&P 500   2,606.15 (+2.54%)
DOW   22,128.89 (+2.27%)
QQQ   190.96 (+3.05%)
AAPL   252.50 (+1.92%)
FB   163.45 (+4.25%)
MSFT   158.88 (+6.13%)
GOOGL   1,135.01 (+2.23%)
AMZN   1,964.98 (+3.41%)
CGC   14.45 (-0.96%)
NVDA   263.09 (+4.10%)
BABA   190.15 (+0.83%)
MU   45.32 (+4.23%)
GE   7.86 (+3.15%)
TSLA   510.21 (-0.81%)
AMD   48.21 (+3.50%)
T   29.86 (-0.07%)
ACB   0.94 (-9.66%)
F   5.01 (-3.47%)
NFLX   373.21 (+4.51%)
BAC   22.22 (+2.87%)
GILD   75.53 (+3.68%)
DIS   97.21 (+0.84%)
Log in

OTCMKTS:ARZTY - ARYZTA AG/ADR Stock Price, Forecast & News

$0.18
-0.03 (-14.12 %)
(As of 03/30/2020 12:46 PM ET)
Today's Range
$0.17
Now: $0.18
$0.21
50-Day Range
$0.19
MA: $0.41
$0.54
52-Week Range
$0.17
Now: $0.18
$0.73
Volume6,195 shs
Average Volume10,705 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ARYZTA AG provides frozen B2B baking solutions in Europe, North America, and internationally. It offers bread rolls and artisan loaves, sweet baked goods and morning goods, and savoury and other products. The company also provides asset management services; and distributes food products. It serves large retail, convenience, and independent retailers, as well as quick service restaurants and other foodservice customers. The company has 56 bakeries in 29 countries. ARYZTA AG was founded in 1897 and is based in Zurich, Switzerland.
Read More

Industry, Sector and Symbol

Industry Food: Specialty/Candy
Sub-IndustryN/A
SectorConsumer Non-Durables
Current SymbolOTCMKTS:ARZTY
CUSIPN/A
CIKN/A
Phone(144) 583-4200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees18,895
Next Earnings DateN/A
OptionableNot Optionable

Receive ARZTY News and Ratings via Email

Sign-up to receive the latest news and ratings for ARZTY and its competitors with MarketBeat's FREE daily newsletter.


ARYZTA AG/ADR (OTCMKTS:ARZTY) Frequently Asked Questions

How has ARYZTA AG/ADR's stock been impacted by COVID-19 (Coronavirus)?

ARYZTA AG/ADR's stock was trading at $0.3680 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ARZTY shares have decreased by 50.4% and is now trading at $0.1825. View which stocks have been mosted impacted by Coronavirus.

Has ARYZTA AG/ADR been receiving favorable news coverage?

Media headlines about ARZTY stock have been trending very positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ARYZTA AG/ADR earned a media sentiment score of 4.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutARYZTA AG/ADR.

Who are some of ARYZTA AG/ADR's key competitors?

What other stocks do shareholders of ARYZTA AG/ADR own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ARYZTA AG/ADR investors own include First Solar (FSLR), Eyepoint Pharmaceuticals (EYPT), Euronet Worldwide (EEFT), Sorrento Therapeutics (SRNE), CVS Health (CVS), Cisco Systems (CSCO), Vodafone Group (VOD), Reckitt Benckiser Group (RB), Greencore Group (GNC) and CRH (CRH).

Who are ARYZTA AG/ADR's key executives?

ARYZTA AG/ADR's management team includes the following people:
  • Mr. Kevin E. Toland F.C.M.A., FCMA, CEO & Exec. Director (Age 54)
  • Mr. Anthony Murphy, Chief People Officer (Age 56)
  • Mr. Robert O'Boyle, Chief Operating Officer of APMEA (Age 44)
  • Mr. Frédéric Pflanz, Chief Financial Officer (Age 51)
  • Mr. Paul Meade, Head of Investor Relations

What is ARYZTA AG/ADR's stock symbol?

ARYZTA AG/ADR trades on the OTCMKTS under the ticker symbol "ARZTY."

How do I buy shares of ARYZTA AG/ADR?

Shares of ARZTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ARYZTA AG/ADR's stock price today?

One share of ARZTY stock can currently be purchased for approximately $0.18.

What is ARYZTA AG/ADR's official website?

The official website for ARYZTA AG/ADR is http://www.aryzta.com/.

How can I contact ARYZTA AG/ADR?

The company can be reached via phone at (144) 583-4200.


MarketBeat Community Rating for ARYZTA AG/ADR (OTCMKTS ARZTY)

Community Ranking:  3.5 out of 5 (star star star)
Outperform Votes:  66 (Thanks for Voting!)
Underperform Votes:  27 (Thanks for Voting!)
Total Votes:  93
MarketBeat's community ratings are surveys of what our community members think about ARYZTA AG/ADR and other stocks. Vote "Outperform" if you believe ARZTY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ARZTY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel